Pain measures may help track treatment response in Graves’ orbitopathy
Patients with Graves’ orbitopathy (GO) reported improvements in pain and quality of life following intravenous methylprednisolone (IVMP) treatment, according to a study. Researchers evaluated 40 patients with GO before treatment and again at 12 and 24 weeks after starting IVMP. Pain was assessed using numeric rating scale (NRS) scores for spontaneous retrobulbar pain, pain during... ...